ARTICLE | Company News
Actimis Pharmaceuticals pulmonary, inflammation news
February 9, 2009 8:00 AM UTC
Actimis completed its previously announced spinout of Axikin Pharmaceuticals Inc. to develop four undisclosed preclinical small molecules to treat severe respiratory, inflammatory and autoimmune dise...